Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Survival benefit of Olaparib in 1st-line advanced ovarian cancer as a monotherapy & in combination with bevacizumab
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 배재만 | - |
| dc.date.accessioned | 2025-01-09T04:00:26Z | - |
| dc.date.available | 2025-01-09T04:00:26Z | - |
| dc.date.issued | 2024-11-16 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/205168 | - |
| dc.title | Survival benefit of Olaparib in 1st-line advanced ovarian cancer as a monotherapy & in combination with bevacizumab | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | KGOG 2024 Fall Semi-Annual Meeting | - |
| dc.citation.conferencePlace | 송도 연세대학교 국제캠퍼스 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 산부인과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Bae, Jae man
- 서울 의과대학 (DEPARTMENT OF OBSTETRICS AND GYNECOLOGY)